Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that its ...

22 Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary Objectives To develop EULAR recommendations for screening and prophylaxis of chronic and opportunistic ...